Renaissance Technologies
INAB icon

Renaissance Technologies’s IN8bio INAB Stock Holding History

Renaissance Technologies’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,972
Closed -$141K – 3719
2024
Q1 		$141K Buy
3,972
+3,319
+508% +$125K ﹤0.01% 3299
2023
Q4 		$27K Buy
+653
New +$20.9K ﹤0.01% 3546
2023
Q3 		– Sell
-723
Closed -$33K – 3873
2023
Q2 		$33K Buy
+723
New +$45.2K ﹤0.01% 3686

Other funds holding INAB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Renaissance Technologies's INAB Position: Q2 2024 in Review

Renaissance Technologies sold out of IN8bio (INAB) in Q2 2024, closing a stake of 3,972 shares — an estimated $141K sold.

Renaissance Technologies first reported a position in INAB in Q2 2023 and held it in 3 quarters. The position peaked at $141K in Q1 2024. 26 funds tracked by Wall St. Rank hold INAB as of Q2 2024.

  • Renaissance Technologies reported no remaining IN8bio position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 3,972 IN8bio shares in Q2 2024, an estimated $141K.
  • Renaissance Technologies first reported a position in IN8bio in Q2 2023 and held it in 3 quarters.
  • Renaissance Technologies's IN8bio position peaked at $141K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held IN8bio as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.